Only one of four patients persisted with Novo Nordisk's (NVO) newer GLP-1 drugs, Wegovy or Ozempic, two years after taking ...
An older drug in the same GLP-1 class as Ozempic, Wegovy, Mounjaro and Zepbound appeared to protect the brain from shrinking ...
Researchers from Monell Chemical Senses Center have identified a specific population of neurons in the brain that could be ...
The research team analyzed the electronic health records of nearly 229,000 patients with both Type 2 diabetes and TUD from ...
People taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration ...
Who should receive Ozempic and GLP-1 drugs given their high demand and limited supply? Experts debate prioritizing those with ...
Noom, Calibrate, and Embla tell customers they can stop taking GLP-1s and keep off the weight they’ve lost. Doctors and drug manufacturers disagree.
The next wave of obesity drugs could help people lose even more weight—and make some pharma companies a fortune.
A weight loss drug similar to Ozempic appeared to slow cognitive decline in patients with mild Alzheimer’s disease, new ...
Share on Pinterest GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound can affect people differently. BONNINSTUDIO/Stocksy United Misconceptions about the benefits and risks of GLP-1 drugs like ...
An Alzheimer’s study reported liraglutide appeared to slow cognitive decline compared to a placebo. Researchers plan more testing to confirm.
Research shows the drug can cut the risk of serious cardiovascular issues like heart attack and stroke in certain patients.